The Montreal Clinical Research Institute (IRCM) marked International Rare Disease Day by opening its Genetic Dyslipidemia Clinic. The event was attended by Pierre Fitzgibbon, Minister of Economy and Innovation, Danielle McCann, Minister of Health and Social Services, as well as patients and representatives from the research and the health community.
In operation since 2016, the IRCM's Research Centre on Rare and Genetic Diseases in Adults is an institutional initiative that aims to address a major gap in the health system: the care of adult patients living with a rare disease.
• A rare disease is a disease that affects less than 1 person in 2,000.
• An orphan disease is a rare disease for which no effective treatment exists to date.
• About 8,000 rare diseases have been identified so far.
• In Quebec, more than 500,000 people live with a rare disease (2.5 million in Canada).
What are genetic dyslipidemias?
Genetic dyslipidemias result in a significant increase in blood cholesterol or triglyceride levels, even when following dietary and lifestyle recommendations. When not properly treated, they can lead to cardiovascular or pancreatic complications.
Affiliations and associations
The IRCM is affiliated with Université de Montréal and associated with McGill University. The IRCM Clinic is affiliated with the Centre hospitalier de l'Université de Montréal (CHUM).
“The IRCM is a model of excellence in biomedical research, as well as a source of innovation and inspiration for several research centres in Québec and around the world. The inauguration of this new genetic dyslipidemia clinic clearly illustrates that it is possible to improve the quality of life of Quebecers by promoting research. In addition, by making possible major scientific breakthroughs, our support for life sciences allows us to develop a key economic sector for the Government of Québec.”
Pierre Fitzgibbon, Minister of Economy and Innovation
“The inauguration of this clinic is excellent news for people with genetic dyslipidemia and their families. It is essential to continue research in order to continually improve the screening, diagnosis and treatment of these diseases so that personalised care can be provided and the quality of life for many people in Quebec can be improved. Thank you to all of the IRCM’s teams for their efforts, but especially for their dedication as well as their ability to be attentive to patients and their needs.”
Danielle McCann, Minister of Health and Social Services
“Our centre aims to better understand these diseases and develop new treatments for adult patients thanks to state-of-the-art biomedical research. Our goal is to provide patients with an environment where they will be supported by a multidisciplinary team and will be able to benefit from an improved quality of life thanks to new treatments that are adapted to them.”
Tarik Möröy, President and Scientific Director of the IRCM
“The launching of the IRCM’s Genetic Dyslipidemia Clinic is another step forward in rare disease research. This is the third clinic hosted by the Institute's Research Centre on Rare and Genetic Diseases in Adults, opened in 2016, which already has a Primary Immunodeficiency Clinic and a Rare Kidney Disease Clinic.”
Sophie Bernard, Director of the IRCM Genetic Dyslipidemia Clinic, Director of the IRCM Lipids, Nutrition and Cardiovascular Prevention Clinic, Acting Vice President, Clinical and Clinical Research, of the IRCM, and Assistant Professor in the Department of Medicine at the Faculty of Medicine of Université de Montréal